Reconceptualizing Vaccine Approaches Across the Development Pipeline
Time: 3:15 pm
day: Day One
Details:
- What opportunities/advantages do mRNA- based vaccines offer against infectious diseases and how to accelerate success?
- Learning from current pandemic and past infectious diseases for designing more potent vaccines
- Regulatory standards for saRNA vaccines (revisiting criteria beyond VNT)
